Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Research Articles, Systems/Circuits

High-Frequency Neuronal Bursting is Essential for Circadian and Sleep Behaviors in Drosophila

Florencia Fernandez-Chiappe, Lia Frenkel, Carina Celeste Colque, Ana Ricciuti, Bryan Hahm, Karina Cerredo, Nara Inés Muraro and María Fernanda Ceriani
Journal of Neuroscience 27 January 2021, 41 (4) 689-710; https://doi.org/10.1523/JNEUROSCI.2322-20.2020
Florencia Fernandez-Chiappe
1Instituto de Investigación en Biomedicina de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lia Frenkel
2Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1405BWE, Argentina
3Instituto de Biociencias, Biotecnología y Biología traslacional (IB3), Departamento de Fisiología Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carina Celeste Colque
2Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1405BWE, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Ricciuti
1Instituto de Investigación en Biomedicina de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Hahm
1Instituto de Investigación en Biomedicina de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karina Cerredo
1Instituto de Investigación en Biomedicina de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nara Inés Muraro
1Instituto de Investigación en Biomedicina de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina
2Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1405BWE, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nara Inés Muraro
María Fernanda Ceriani
2Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires C1405BWE, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María Fernanda Ceriani
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Ih genetic manipulations disrupt circadian locomotor activity organization. Representative double-plotted actograms of the different Ih genetic manipulations tested. A, LNvs constitutive downregulation of Ih using pdf,dicer and UAS-IhRNAi (in all cases, UAS-IhRNAi refers to the genetic combination of two UAS-IhRNAi constructs: DRSC 29574 + VDRC KK 110274) and genetic controls. B, LNvs acute downregulation of Ih using pdfGS and UAS-IhRNAi and genetic controls. RU refers to the presence of the steroid RU486, the activator of the GS system, in the food media. C, Homozygote Ih null mutants, Ihf01485 and Ihf03355, and controls (w1118 and heterozygote mutants, crossed by w1118). In the case of the experimental genotypes an actogram of an arrhythmic individual is shown, different genetic manipulations varied in the degree of arrhythmicity (see Table 3). No statistically significant alterations in free running period were found for these genetic manipulations.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Ih is important for high-frequency bursting of LNvs. A, Representative traces of whole-cell patch clamp recordings of lLNvs of control (pdf-RFP, top) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP, bottom). B, Representative trace of a recording of a sLNv control (pdf-RFP) in whole-cell patch clamp configuration. C, Representative traces of cell-attached recordings of sLNvs of control (pdf-RFP, top) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP, bottom). D, Box plot showing the median and interquartile range of the bursting frequency quantification of lLNvs and sLNvs of control (pdf-RFP) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP). All quantifications were done at exactly 23 min postdissection. Different letters indicate significant differences (p < 0.05) after a one-way ANOVA with Tukey's test for means comparisons. n: lLNvsCONTROL = 14, lLNvsIhf03355 = 12, sLNvsCONTROL = 10, sLNvsIhf03355 = 7.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Mutation of Ih does not significantly affect other electrophysiological parameters of LNvs. A, No statistical significant differences were found in action potential firing rate of lLNvs when comparing control (pdf-RFP) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP). B, No statistical significant differences were found in membrane potential (measured as the trough between bursts) of lLNvs when comparing control (pdf-RFP) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP). C, No statistical significant differences were found in action potential firing rate of sLNvs when comparing control (pdf-RFP) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP). Membrane potential was not quantified in sLNvs as recordings were made in cell-attached configuration, and it is not possible to measure this parameter under this configuration. All quantifications were done at exactly 23 min postdissection. In all cases, p > 0.05 after Student's t test. n: lLNvsCONTROL = 7, lLNvsIhf03355 = 8, sLNvsCONTROL = 7, sLNvsIhf03355 = 6.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    sLNvs bursting depends on synaptic inputs. As has been demonstrated before for lLNvs (Muraro and Ceriani, 2015), we show here that sLNvs bursting frequency also decays as a function of the time ex vivo. A, The number of bursts in the initial minute of recording of nine individual control (pdf-RFP) sLNvs recorded at different times postdissection is shown. For the late points the preparation was left in the chamber on purpose before establishing the recording. B, Shows the bursting frequency of five individual control (pdf-RFP) sLNvs where the recordings were long enough to appreciate the decay in this parameter as a function of time postdissection not only as a population as in A, but as individual cells. C, Shows 30-s windows of cell-attached recording of a representative sLNv (sLNv3 in B) at different times postdissection. From top to bottom, the 30 s starting at 25, 35, 45, and 55 min postdissection are shown. At the beginning of the recording, all action potentials are organized in bursts. As time passes, action potentials become less organized in bursts, going through a phase of bursting-tonic firing and becoming purely tonic toward the end. This figure shows that the fact that in A, B the neurons have a tendency toward the cero bursting frequency does not mean that the neurons are not firing, but that they are doing so in a tonic mode. D, Box plot showing the median and interquartile range of the bursting frequency quantification of lLNvs and sLNvs of control (pdf-RFP) and Ih homozygote mutant genotypes (Ihf03355; pdf-RFP), these quantifications were done at exactly 33 min postdissection. Different letters indicate significant differences (p < 0.05) after a one-way ANOVA with Tukey's test for means comparisons. n: lLNvsCONTROL = 7, lLNvsIhf03355 = 8, sLNvsCONTROL = 8, sLNvsIhf03355 = 5.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Ih downregulation affects PDF levels and structural plasticity. A, Confocal images of representative sLNvs dorsal projections of individual flies of control (pdfGS/+) and Ih downregulation (pdfGS>IhRNAi) at day (top) and night (bottom) showing their PDF content. Flies were kept in LD 12:12 at 25°C for 7 d in food containing RU486. Brains were dissected at ZT02 and ZT14 and standard anti-PDF immunofluorescence detection was performed. The bar indicates 10 µm. B, PDF quantitation of the sLNvs dorsal projections for the four conditions mentioned before. Circles represent day time, squares, night time; empty symbols are the control genotype (pdfGS/+) and filled symbols, the experimental one (pdfGS>IhRNAi). Different letters indicate significant differences, analysis included a two-way ANOVA (genotype and time of day; F(3,150) = 18.58 p < 0.0001 with Tukey's post hoc test, α = 0.05), n = 35–43 per group. C, Confocal images of sLNvs projections illustrating their complexity at ZT02 and ZT14 for both in the control and Ih downregulated genotypes. Procedure as in A but with immunofluorescence against GFP. The bar indicates 10 µm. D, Complexity quantitation was asses by Sholl analysis (ImageJ) corroborated by visual inspection of each picture. Symbols as in B, analysis included a two-way ANOVA (F(3,123) = 4.24 p < 0.01 with Tukey's post hoc test, α = 0.05). In B and D the mean ± SEM are shown. Different letters indicate significant differences. n = 34–38 per group.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    PDF transport is affected on Ih manipulation. A, B, Confocal images of representative sLNv projections (A) and somas (B) of individual flies of pdfGS/+ (control), pdfGS>IhRNAi (Ih), pdfGS>UAS-pdf (pdfOX) and pdfGS>UAS-pdf, IhRNAi (pdfOX, Ih) at day (left) and night (right) showing their PDF content. Flies were kept in LD 12:12 at 25°C for 7 d in food containing RU486. Brains were dissected at ZT02 and ZT14 and standard anti-PDF immunofluorescence detection was performed. Bars indicate 10 µm. C, E, PDF quantitation of the sLNv dorsal projections (C) or somas (E) for the four genotypes mentioned before. Circles represent day time, squares, night time; each color is a different genotype. Asterisks represent significant statistical differences. For the projections, a non-parametric ANOVA Kruskal–Wallis test and Dunn's comparisons test showed differences among the two time points in control, pdfOX and pdfOX, Ih groups but not in Ih group (Kruskal–Wallis statistic(8,196) = 71.95, p < 0.0001, n = 18–28). Immunoreactivity from somas was analyzed with one-way ANOVA and Sidak's multiple comparisons test and revealed differences between the two time points in every genotype except pdfOX, although in Ih and pdfOX, Ih showed differences in the anti-phase direction compared with the control, ANOVA F(7,120) = 10.95, p < 0.0001, n = 10–22 (each point is the average of three to four cell somas for one hemi-brain of an individual fly). D, F, Morning to evening PDF level ratios for axonal projections (D) or somas (F). G, Locomotor behavior under constant darkness of the same genotypes as before. Experiments were performed as in Figure 1 and Table 3. The rhythmicity measured as power-significance was analyzed by Kruskal–Wallis test followed by Dunn's comparisons test and showed a significant reduction of power-significance in Ih and pdfOX, Ih compared with control and pdfOX as indicated by different letters (Kruskal–Wallis statistic(4,31) = 31.40, p < 0.0001, n = 65–72). H, Free running period values were analyzed as well. The same type of analysis reveals a reduction of tau in pdfOX, Ih compared with all the other genotypes as indicated by a different letter (Kruskal–Wallis statistic(4,31) = 38.28, p < 0.0001, n = 45–58). In C, G and H the median ± confidence intervals are shown. In E the mean ± Standard Deviation is shown. ns, not significant.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Genetic manipulations of Ih increase sleep. A, E, I, Sleep ethograms for the indicated genotypes, quantification of the relative amount of sleep every 30 min as a function of the time of the day (starting at ZT = 0, when lights are turned on) and its standard deviation (shadowed area). Black and white bars at the bottom represent daytime (white) and nighttime (black). B, F, J, Boxplots showing the total amount of sleep minutes for each genotype. C, G, K, Boxplots showing the average duration of sleep episodes for each genotype. D, H, L, Boxplots showing the total amount of sleep episodes for each genotype. For all the boxplots, different letters indicate significant differences (p < 0.05) after non parametric Kruskal–Wallis statistical analysis with multiple comparisons (p adjustment method = BH). Box represents the median and interquartile range of each parameter. For more information on sleep parameters see Table 5.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Relative contribution of specific clusters to sleep control. Boxplots show daytime and nighttime sleep duration on RNAi-mediated Ih downregulation using c929-Gal4 (top panel), R6-Gal4 (middle panel), and pdf-Gal4 (bottom panel), along with their genetic controls. Adult-specific manipulations performed using the TARGET system are shown in the left and correspond to the second day at the permissive temperature of 30°C. Constitutive genetic manipulations are shown on the right, all performed at the standard temperature of 25°C. Different letters indicate significant differences (p < 0.05) after non parametric Kruskal–Wallis statistical analysis with multiple comparisons (p adjustment method = BH). Box represents the median and interquartile range of each parameter. For more detailed information on sleep parameters see Table 5.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Model summarizing the findings reported and the hypotheses raised by this work. Ih channel (in green) responds to membrane hyperpolarization and is modulated by cyclic nucleotides, serving as coincidence detector for electrical and chemical signals mediated by ligands that activate G-protein-coupled receptors (such as PDF, dopamine, or other neuropeptides, symbolized by “modulator,” in blue). Ih function is necessary to allow LNvs to fire action potentials in a high-frequency bursting mode, which permits the release of PDF (in orange) at high levels and in a timely manner (top neuron). In the absence or on Ih knock-down (bottom neuron), bursting does not reach such high frequency, and PDF levels at the axonal projections are reduced. Associated to the decreased bursting frequency, large quantities of PDF accumulate at the soma, likely because of a failure in DVCs transport. This may give rise to a hypothetical aberrant PDF release from the overloaded soma, likely overriding the internal temporal control. All in all, these cellular disruptions result in anomalies at the behavioral level, such as disorganization of circadian locomotor activity and an increase in sleep. At the level of the axonal projections, the model represents an early daytime situation, where in control animals PDF levels are high and the axonal terminal are spread out. However, the accumulation and possible aberrant release of PDF from the soma is more likely to happen during the night (Fig. 6).

Tables

  • Figures
    • View popup
    Table 1.

    Reagents and resources used for this work

    Reagent or resourceSourceIdentifier
    Antibodies
        Rat polyclonal anti-PDFDepetris-Chauvin et al. (2011)N/A
        Chicken polyclonal anti-GFPAves LabCatalog #GFP-1020, RRID:AB_10000240
        Alexa Fluor 647-AffiniPure Donkey Anti-RatJackson ImmunoResearchcatalog #712-605-150, RRID:AB_2340693
        Cy2-AffiniPure Donkey Anti-ChickenJackson ImmunoResearchcatalog #703-225-155, RRID:AB_2340370
    Chemicals
        NaCl, sodium chlorideSigma-AldrichS7653; CAS: 7647-14-5 (BioXtra, ≥99.5%; AT)
        KCl, potassium chlorideSigma-AldrichP3911; CAS: 7447-40-7 (ACS reagent, 99.0–100.5%)
        CaCl2.2H2O, calcium chloride dihydrateSigma-Aldrich223506; CAS: 10035-04-8 (ACS reagent, ≥99%)
        MgCl2.6H2O, magnesium chloride hexahydrateSigma-AldrichM2670; CAS: 7791-18-6 (BioXtra, ≥99.0%)
        NaH2PO4, sodium phosphate monobasicSigma-AldrichS8282; CAS: 7558-80-7 (BioXtra, ≥99.0%)
        NaHCO3, sodium bicarbonateSigma-AldrichS6297; CAS: 144-55-8 (BioXtra, 99.5–100.5%)
        D-(+)-glucoseSigma-AldrichG8270; CAS: 50-99-7 (≥99.5%; GC)
        Protease from Streptomyces griseusSigma-AldrichP5147; CAS: 9036-06-0 (Type XIV, ≥3.5 units/mg solid, powder)
        Potassium D-gluconateSigma-AldrichG4500; CAS: 299-27-4 (≥99%)
        EGTASigma-AldrichE3889; CAS: 67-42-5 (for molecular biology, ≥97.0%)
        HEPESSigma-AldrichH3375; CAS: 7365-45-9 (≥99.5%; titration)
        RU-486, mifepristoneSigma-AldrichM8046, CAS: 84371-65-3 (≥98%)
        ParaformaldehydeSigma-Aldrich441244; CAS: 30525-89-4
        NaCl, sodium chloride (for PBS solution)Cicarelli Laboratorios750; CAS: 7647-14-5
        Na2HPO4, sodium phosphate dibasicSigma-AldrichS3264; CAS: 7558-79-4 (for molecular biology, ≥98.5%; titration)
        Triton X-100Sigma-AldrichT9284; CAS: 9002-93-1 (BioXtra)
        Goat serumNatocor734
        Vetbond tissue adhesive3 M1469SB
    Organisms/strains
        D. melanogaster: w1118Bloomington Drosophila Stock CenterBDSC: 5905; FlyBase: FBal0018186
        D. melanogaster: pdf-GAL: y[1] w[*]; P{w[+mC]=Pdf-GAL4.P2.4}2Bloomington Drosophila Stock CenterBDSC: previously 6900, now available as part of 25031; FlyBase: FBtp0011844
        D. melanogaster: UAS-CD8::GFP: y[1] w[*]; P{w[+mC]=UAS-mCD8::GFP.L}LL5, P{UAS-mCD8::GFP.L}2Bloomington Drosophila Stock CenterBDSC: 5137; FlyBase: FBst0005137
        D. melanogaster: c929-Gal4: w[*]; P{w[+mW. h]=GawB}dimm[929] crc[929]Bloomington Drosophila Stock CenterBDSC:25373; FlyBase: FBst0025373
        D. melanogaster: tub-Gal80TS: w[*]; P{w[+mC]=tubP-GAL80[ts]}2/TM2Bloomington Drosophila Stock CenterBDSC: 7017; FlyBase:
    FBst0007017
        D. melanogaster: pdfGS: w*; P{UAS-mCD8::GFP.L}LL5; P{Pdf-GS}3/TM3, Sb1Bloomington Drosophila Stock Center
    Depetris-Chauvin et al. (2011)
    BDSC: 80956
    FlyBase:
    FBst0080956
        D. melanogaster: UAS-dicer2: w[1118]; P{UAS-dicer2, w[+]}VDRCVDRC ID: 60008
        D. melanogaster: R6-Gal4: P{?GawB}crcR6Helfrich-Forster et al. (2007)FlyBase: FBti0016844
        D. melanogaster: pdf-RFP: Pdf-RFP transgene has 0.6 kb of Pdf regulatory genomic DNA 0.5 kb upstream the start site of transcription and 0.1 kb downstream) fused to DNA encoding mRFP1, a monomeric soluble red fluorescent protein (Shaner et al., 2004). Injected into y w flies.Ruben et al. (2012)FlyBase: FBrf0219602
        D. melanogaster: Ihf01485: PBac{WH}Ihf01485Exelixis at Harvard Medical SchoolFlyBase:
    FBst1017022
        D. melanogaster: Ihf03355: PBac{WH}Ihf03355Exelixis at Harvard Medical SchoolFlyBase:
    FBst1018427
        D. melanogaster: RNAi of cac: P{KK101478}VIE-260BVDRCVDRC ID: 104168
    FlyBase:
    FBst0476026
        D. melanogaster: RNAi of cac: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02572}attP2Bloomington Drosophila Stock CenterBDSC: 27244; FlyBase: FBst0027244
        D. melanogaster: RNAi of Ca-α1T: P{KK100082}VIE-260BVDRCVDRC ID: 108827
    FlyBase:
    FBst0480621
        D. melanogaster: RNAi of ClC-a: P{KK101247}VIE-260BVDRCVDRC ID: 110394
    FlyBase:
    FBst0481966
        D. melanogaster: RNAi of CngA: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02039}attP2Bloomington Drosophila Stock CenterBDSC: 26014; FlyBase: FBst0026014
        D. melanogaster: RNAi of CngA: P{KK108314}VIE-260BVDRCVDRC ID: 101745
    FlyBase: FBst0473618
        D. melanogaster: RNAi of Ih: P{KK100190}VIE-260BVDRCVDRC ID: 110274
    FlyBase:
    FBst0481852
        D. melanogaster: RNAi of Ih: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03253}attP2Bloomington Drosophila Stock CenterBDSC:29574; FlyBase: FBst0029574
        D. melanogaster: RNAi of Ork1: P{KK107843}VIE-260BVDRCVDRC ID: 104883
    FlyBase:
    FBst0476711
        D. melanogaster: RNAi of Ork1: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01926}attP2Bloomington Drosophila Stock CenterBDSC:25855; FlyBase: FBst0025885
        D. melanogaster: RNAi of Shal on the III chromosomeNIG Fly Stock CenterNIG Stock ID: 9262R-3
        D. melanogaster: RNAi of tipE on the III chromosomeNIG Fly Stock CenterNIG Stock ID: 1232R-3
        D. melanogaster: RNAi of tipE: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02148}attP2/TM3, Sb[1]Bloomington Drosophila Stock CenterBDSC:26249; FlyBase: FBst0026249
        D. melanogaster: RNAi of Atpα: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02910}attP2Bloomington Drosophila Stock CenterBDSC: 28073;
    FlyBase: FBst0028073
        D. melanogaster: RNAi of Atpα: P{KK108782}VIE-260BVDRCVDRC ID: 100619
    FlyBase:
    FBst0472492
        D. melanogaster: RNAi of Calx: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02937}attP2Bloomington Drosophila Stock CenterBDSC: 28306;
    FlyBase:
    FBst0028306
        D. melanogaster: RNAi of Calx: P{KK109144}VIE-260BVDRCVDRC ID: 104789
    FlyBase:
    FBst0476622
        D. melanogaster: RNAi of Ca-α1D: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01848}attP2Bloomington Drosophila Stock CenterBDSC: 25830;
    FlyBase:
    FBst0025830
        D. melanogaster: RNAi of Ca-α1D: w[1118]; P{GD1737}v51490/CyOVDRCVDRC ID: 51490
    FlyBase:
    FBst0469449
        D. melanogaster: RNAi of Ca-α1T: w[1118]; P{GD7754}v31963VDRCVDRC ID: 31963
    FlyBase:
    FBst0459316
        D. melanogaster: RNAi of Ca-α1T: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02150}attP2Bloomington Drosophila Stock CenterBDSC: 26251;
    FlyBase:
    FBst0026251
        D. melanogaster: RNAi of eag: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01471}attP2Bloomington Drosophila Stock CenterBDSC: 31678;
    FlyBase:
    FBst0031678
        D. melanogaster: RNAi of eag: P{KK107309}VIE-260BVDRCVDRC ID: 100260
    FlyBase:
    FBst0472134
        D. melanogaster: RNAi of Hk: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02965}attP2/TM3, Sb[1]Bloomington Drosophila Stock CenterBDSC: 28330;
    FlyBase:
    FBst0028330
        D. melanogaster: RNAi of Hk: P{KK109058}VIE-260BVDRCVDRC ID: 101402
    FlyBase:
    FBst0473275
        D. melanogaster: RNAi of inx2: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02446}attP2Bloomington Drosophila Stock CenterBDSC: 29603;
    FlyBase:
    FBst0029306
        D. melanogaster: RNAi of inx2: P{KK111067}VIE-260BVDRCVDRC ID: 102194
    FlyBase:
    FBst0474063
        D. melanogaster: RNAi of Ir: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01841}attP2Bloomington Drosophila Stock CenterBDSC: 25823;
    FlyBase:
    FBst0025823
        D. melanogaster: RNAi of Ir: P{KK102249}VIE-260BVDRCVDRC ID: 107389
    FlyBase:
    FBst0479211
        D. melanogaster: RNAi of Irk2: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01838}attP2Bloomington Drosophila Stock CenterBDSC: 25820;
    FlyBase:
    FBst0025820
        D. melanogaster: RNAi of Irk2: w[1118]; P{GD203}v4341VDRCVDRC ID: 4341
    FlyBase:
    FBst0465076
        D. melanogaster: RNAi of KCNQ: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02562}attP2Bloomington Drosophila Stock CenterBDSC: 27252;
    FlyBase:
    FBst0027252
        D. melanogaster: RNAi of KCNQ: P{KK109039}VIE-260BVDRCVDRC ID: 106655
    FlyBase:
    FBst0478479
        D. melanogaster: RNAi of Ncc69: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03097}attP2Bloomington Drosophila Stock CenterBDSC: 28682;
    FlyBase:
    FBst0028682
        D. melanogaster: RNAi of Ncc69: P{KK108763}VIE-260BVDRCVDRC ID: 106499
    FlyBase:
    FBst0478323
        D. melanogaster: RNAi of Nckx30C: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02574}attP2Bloomington Drosophila Stock CenterBDSC: 27246;
    FlyBase:
    FBst0027246
        D. melanogaster: RNAi of nrv1: w[1118] P{GD959}v46542VDRCVDRC ID: 46542
    FlyBase:
    FBst0466759
        D. melanogaster: RNAi of nrv1: P{KK100406}VIE-260BVDRCVDRC ID: 103702
    FlyBase:
    FBst0475560
        D. melanogaster: RNAi of nrv2: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03081}attP2Bloomington Drosophila Stock CenterBDSC: 28666;
    FlyBase:
    FBst0028666
        D. melanogaster: RNAi of nrv2: w[1118]; P{GD960}v2660VDRCVDRC ID: 2660
    FlyBase:
    FBst0456497
        D. melanogaster: RNAi of para: w[1118]; P{GD3392}v6131VDRCVDRC ID: 6131
    FlyBase:
    FBst0470199
        D. melanogaster: RNAi of para: P{KK108534}VIE-260BVDRCVDRC ID: 104775
    FlyBase:
    FBst0476611
        D. melanogaster: RNAi of picot: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01940}attP2Bloomington Drosophila Stock CenterBDSC: 25920;
    FlyBase:
    FBst0025920
        D. melanogaster: RNAi of picot: P{KK106848}VIE-260BVDRCVDRC ID: 101082
    FlyBase:
    FBst0472955
        D. melanogaster: RNAi of ppk: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03250}attP2Bloomington Drosophila Stock CenterBDSC: 29571;
    FlyBase:
    FBst0029571
        D. melanogaster: RNAi of ppk: P{KK104185}VIE-260BVDRCVDRC ID: 108683
    FlyBase:
    FBst0480493
        D. melanogaster: RNAi of ppk12: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02027}attP2Bloomington Drosophila Stock CenterBDSC: 27092;
    FlyBase:
    FBst0027092
        D. melanogaster: RNAi of ppk12: P{KK101805}VIE-260BVDRCVDRC ID: 105131
    FlyBase:
    FBst0476959
        D. melanogaster: RNAi of ppk25: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02434}attP2Bloomington Drosophila Stock CenterBDSC: 27088;
    FlyBase:
    FBst0027088
        D. melanogaster: RNAi of ppk25: P{KK109736}VIE-260BVDRCVDRC ID: 101808
    FlyBase:
    FBst0473681
        D. melanogaster: RNAi of ppk28: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02153}attP2Bloomington Drosophila Stock CenterBDSC: 31878;
    FlyBase:
    FBst0031878
        D. melanogaster: RNAi of ppk28: P{KK106316}VIE-260BVDRCVDRC ID: 100946
    FlyBase:
    FBst0472819
        D. melanogaster: RNAi of sei: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01474}attP2/TM3, Ser[1]Bloomington Drosophila Stock CenterBDSC: 31681;
    FlyBase:
    FBst0031681
        D. melanogaster: RNAi of sei: P{KK105733}VIE-260BVDRCVDRC ID: 104698
    FlyBase:
    FBst0476547
        D. melanogaster: RNAi of Sh: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01473}attP2/TM3, Ser[1]Bloomington Drosophila Stock CenterBDSC: 31680;
    FlyBase:
    FBst0031680
        D. melanogaster: RNAi of Sh: P{KK109112}VIE-260BVDRCVDRC ID: 104474
    FlyBase:
    FBst0476332
        D. melanogaster: RNAi of Shal: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02154}attP2Bloomington Drosophila Stock CenterBDSC: 31879;
    FlyBase:
    FBst0031879
        D. melanogaster: RNAi of Shaw: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02982}attP2Bloomington Drosophila Stock CenterBDSC: 28346;
    FlyBase:
    FBst0028346
        D. melanogaster: RNAi of Shaw: P{KK108371}VIE-260BVDRCVDRC ID: 110589
    FlyBase:
    FBst0482154
        D. melanogaster: RNAi of SK: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02571}attP2Bloomington Drosophila Stock CenterBDSC: 27238;
    FlyBase:
    FBst0027238
        D. melanogaster: RNAi of SK: P{KK107699}VIE-260BVDRCVDRC ID: 103985
    FlyBase:
    FBst0475843
        D. melanogaster: RNAi of SLO2: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF03426}attP2Bloomington Drosophila Stock CenterBDSC: 32034;
    FlyBase:
    FBst0032034
        D. melanogaster: RNAi of stj: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01825}attP2Bloomington Drosophila Stock CenterBDSC: 25807;
    FlyBase:
    FBst0025807
        D. melanogaster: RNAi of stj: P{KK101267}VIE-260BVDRCVDRC ID: 108569
    FlyBase:
    FBst0480379
        D. melanogaster: RNAi of Teh2: w[1118]; P{GD3839}v9037VDRCVDRC ID: 9037
    FlyBase:
    FBst0471346
        D. melanogaster: RNAi of Teh2: P{KK112449}VIE-260BVDRCVDRC ID: 104951
    FlyBase:
    FBst0476779
        D. melanogaster: RNAi of Teh4: w[1118]; P{GD3578}v11621/CyOVDRCVDRC ID: 11621
    FlyBase:
    FBst0450303
        D. melanogaster: RNAi of Teh4: P{KK110985}VIE-260BVDRCVDRC ID: 102161
    FlyBase:
    FBst0474030
        D. melanogaster: RNAi of trp: y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF01441}attP2Bloomington Drosophila Stock CenterBDSC: 31649;
    FlyBase:
    FBst0031649
        D. melanogaster: RNAi of trp: w[1118]; P{GD372}v1366VDRCVDRC ID: 1366
    FlyBase:
    FBst0451102
        D. melanogaster: UAS-pdf on the 2nd ChromosomeRenn et al. (1999)N/A
    Software
        ImageJSchneider et al. (2012)https://imagej.nih.gov/ij/
        InfostatDi Rienzo et al. (2018)https://www.infostat.com.ar/
        ClockLabActimetricshttps://www.actimetrics.com/products/clocklab/
        RethomicsGeissmann et al. (2019)https://rethomics.github.io/
        RR Core Team (2014)https://www.r-project.org/
        Micro ManagerEdelstein et al. (2014)https://micro-manager.org/wiki/Download_Micro-Manager_Latest_Release
        pClamp 9Molecular Deviceshttps://moleculardevices.app.box.com/s/d93nukl3chbo206t33cw5fpabsph6wh4
        Clampfit 10Molecular Deviceshttps://moleculardevices.app.box.com/s/l8h8odzbdikalbje1iwj85x88004f588
        Origin 8OriginLabhttps://www.originlab.com/
        GraphPadPrism8https://www.graphpad.com/
    • View popup
    Table 2.

    Positive hits of the ion channel downregulation behavioral screen

    Gene symbolCGRNAi infoChannel typeTau (h)Rhythm (%)nN
    Pdf,dcr>cacCG1522DRSC 27244 + VDRC KK 104168VG Ca++ channel24.48 ± 0.21*57 ± 11*755
    +>cac23.79 ± 0.0797 ± 2935
    Pdf,dcr>+23.93 ± 0.1095 ± 21045
    Pdf,dcr>Ca-α1TCG15899VDRC KK 108827VG Ca++ channel24.85 ± 0.14*30 ± 9*703
    +>Ca-α1T23.93 ± 01184 ± 10823
    Pdf,dcr>+23.82 ± 0.6776 ± 11593
    Pdf,dcr>ClC-aCG1116VDRC KK 110394VG Cl- channel21.78 ± 0.13* and 24.25 ± 0.204 ± 4*372
    +>ClC-a24.00 ± 0.0197 ± 3412
    Pdf,dcr>+24.17 ± 0.0676 ± 15432
    Pdf,dcr>CngACG42701DRSC 26014 + VDRC KK 101745Cyclic-nucleotide G channel23.55 ± 0.0665 ± 2*272
    +>CngA23,73 ± 0,2991 ± 9252
    Pdf,dcr>+24,07 ± 0,1198 ± 1372
    Pdf,dcr>Ork1CG1615DRSC 25885 + VDRC KK 104883K+ leak channel25.00 ± 0.46*48 ± 12*332
    +>Ork124.28 ± 0.29100 ± 0342
    Pdf,dcr>+24.23 ± 0,0598 ± 1302
    Pdf,dcr>ShalCG9262NIG 9262R-3VG K+ channel24.59 ± 0.11*89 ± 6594
    +>Shal23.97 ± 0.2097 ± 3393
    Pdf,dcr>+24.01 ± 0.0598 ± 2674
    Pdf,dcr>tipECG1232NIG 1232R-3VG Na+ auxiliary subunit25.73 ± 0.40*85 ± 12463
    +>tipE23.90 ± 0.0196 ± 4272
    Pdf,dcr>+24.12 ± 0.0498 ± 2553
    Pdf,dcr>tipECG1232DRSC 26249VG Na+ auxiliary subunit25.60 ± 0.38*48 ± 16*473
    +>tipE23.73 ± 0.0496 ± 5302
    Pdf,dcr>+24.12 ± 0.0494 ± 4553
    • This table includes a list of genes that, when downregulated exclusively in LNvs using these particular RNAi constructs, produced statistically significant alterations in free running period and/or percentage of rhythmicity. Values represent the average of mean values of N independent experiments ± SEM, n indicates total number of individuals tested; * indicates statistically significant difference (p < 0.05) after a one-way ANOVA comparing pdf,dicer>RNAi to control genotypes pdf,dicer/+ and RNAi/+. Tukey's test was used for means comparison and Levene's test for checking ANOVA assumption of homogeneity of variance. In the case where information for two RNAi constructs is given, it means that each RNAi on its own did not show significant differences compared with controls, but did show a trend toward an altered phenotype. For that reason, two different RNAis for the same gene were genetically combined to achieve added downregulation strength. In the case of ClC-a, the reduction of rhythmicity was because of the appearance of complex rhythms and not to the deconsolidation of locomotor activity organization; the tau of each component of complex rhythms is given. V: voltage, G: gated, DRSC: Drosophila RNAi Screening Center, VDRC: Vienna Drosophila Resource Center, NIG: National Institute of Genetics. Significant differences (p < 0.05) compared with genetic controls are displayed in boldface.

    • View popup
    Table 3.

    Ih genetic manipulations disrupt circadian locomotor activity organization

    GenotypeDD analysisLD analysis
    Tau (h)Rhythm (%)nNMAIEAInN
    pdf,dicer/+24.00 ± 0.0795 ± 37530.73 ± 0.020.88 ±0.02552
    UAS-IhRNAi/+23.71 ± 0.0292 ± 6390.77 ± 0.030.80 ± 0.0321
    pdf,dicer>UAS-IhRNAi23.95 ± 0.0374 ± 8*400.67 ± 0.030.80 ± 0.0223
    pdfGS/+, RU24.59 ± 0.4197 ± 26430.64 ± 0.010.66 ± 0.02*763
    UAS-IhRNAi/+, RU23.75 ± 0.06100 ± 0410.72 ± 0.020.58 ± 0.0150
    pdfGS>UAS-IhRNAi, RU24.81 ± 0.7557 ± 12*670.59 ± 0.01*0.60 ± 0.0174
    control24.02 ± 0.0596 ± 28640.68 ± 0.030.84 ± 0.02622
    Ihf01485/+23.87 ± 0.0396 ± 3800.71 ± 0.040.89 ± 0.0232
    Ihf0148523.56 ± 0.0560 ± 3*980.55 ± 0.050.65 ± 0.03*34
    Ihf03355/+23.86 ± 0.0599 ± 1960.73 ± 0.030.92 ± 0.0230
    Ihf0335523.88 ± 0.0839 ± 12*1040.51 ± 0.03*0.67 ± 0.03*30
    • DD analysis (left): the average free running period and percentage of rhythmicity of populations of male flies of the indicated genotypes are shown. Values represent the average of N independent experiments ± SEM, n indicates total number of individuals tested; * indicates statistically significant difference (p < 0.05) after a one-way ANOVA comparing experimental genotypes to genetic controls. UAS-IhRNAi refers to the genetic combination of two UAS-IhRNAi constructs: DRSC 29574 + VDRC KK 110274). In the case of the Ih null mutants, Ihf01485 and Ihf03355, homozygotes were compared with a w1118 control and to heterozygotes (Ihf03355 crossed by w1118). RU refers to the presence of the steroid RU486 (200 μg/ml), the activator of the GS system, in the food media. LD analysis (right): morning anticipation index (MAI) and evening anticipation index (EAI) were calculated for the same genotypes. *Indicates statistically significant difference (p < 0.05) after Kruskal–Wallis statistical analysis with Dunn's multiple comparisons test. Significant differences (p – 0.05) compared with genetic controls are displayed in boldface.

    • View popup
    Table 4.

    Negative hits of the ion channel downregulation behavioral screen

    GeneCGRNAi infoChannel typenN
    AtpαCG5670DRSC 28073Na+/K+ ATPase α subunit161
    AtpαCG5670VDRC KK 100619Na+/K+ ATPase α subunit453
    CalxCG5685DRSC 28306Ca++ Na+ antiporter81
    CalxCG5685VDRC KK 104789Ca++ Na+ antiporter131
    Ca-α1DCG4894DRSC 25830VG Ca++ channel161
    Ca-α1DCG4894VDRC GD 51490VG Ca++ channel161
    Ca-α1TCG15899VDRC GD 31963VG Ca++ channel703
    Ca-α1TCG15899DRSC 26251VG Ca++ channel502
    eagCG10952DRSC 31678VG cation channel161
    eagCG10952VDRC KK 100260VG cation channel161
    HkCG43388DRSC 28330VG K+ channel β subunit161
    HkCG43388VDRC KK 101402VG K+ channel β subunit141
    inx2CG4590DRSC 29306Gap junction channel131
    inx2CG4590VDRC KK 102194Gap junction channel91
    IrCG6747DRSC 25823VG K+ channel322
    IrCG6747VDRC KK 107389VG K+ channel151
    Irk2CG4370DRSC 25820Inwardly rectifying K+ channel312
    Irk2CG4370VDRC GD 4341Inwardly rectifying K+ channel131
    KCNQCG33135DRSC 27252VG K+ channel654
    KCNQCG33135VDRC KK 106655VG K+ channel151
    Ncc69CG4357DRSC 28682Na+ K+ Cl- symporter161
    Ncc69CG4357VDRC KK 106499Na+ K+ Cl- symporter161
    Nckx30CCG18660DRSC 27246Na+ K+ Ca++ exchanger151
    nrv1CG9258VDRC GD 46542Na+/K+ ATPase β subunit141
    nrv1CG9258VDRC KK 103702Na+/K+ ATPase β subunit151
    nrv2CG9261DRSC 28666Na+/K+ ATPase β subunit151
    nrv2CG9261VDRC GD 2660Na+/K+ ATPase β subunit232
    paraCG9907VDRC GD 6131VG Na+ channel161
    paraCG9907VDRC KK 104775VG Na+ channel282
    picotCG8098DRSC 25920Phosphate Na+ symporter151
    picotCG8098VDRC KK 101082Phosphate Na+ symporter141
    ppkCG3478DRSC 29571Amiloride-sensitive Na+ channel161
    ppkCG3478VDRC KK 108683Amiloride-sensitive Na+ channel343
    ppk12CG10972DRSC 27092Amiloride-sensitive Na+ channel161
    ppk12CG10972VDRC KK 105131Amiloride-sensitive Na+ channel151
    ppk25CG33349DRSC 27088Amiloride-sensitive Na+ channel161
    ppk25CG33349VDRC KK 101808Amiloride-sensitive Na+ channel161
    ppk28CG4805DRSC 31878Amiloride-sensitive Na+ channel161
    ppk28CG4805VDRC KK 100946Amiloride-sensitive Na+ channel121
    seiCG3182DRSC 31681VG K+ channel151
    seiCG3182VDRC KK 104698VG K+ channel161
    ShCG12348DRSC 31680VG K+ channel161
    ShCG12348VDRC KK 104474VG K+ channel312
    ShalCG9262DRSC 31879VG K+ channel151
    ShawCG2822DRSC 28346VG K+ channel161
    ShawCG2822VDRC KK 110589VG K+ channel161
    SKCG10706DRSC 27238Ca++-activated K+ channel161
    SKCG10706VDRC KK 103985Ca++-activated K+ channel161
    SLO2CG42732DRSC 32034Na+ activated K+ channel161
    stjCG12295DRSC 25807VG Ca++ channel151
    stjCG12295VDRC KK 108569VG Ca++ channel151
    Teh2CG15004VDRC GD 9037VG Na+ auxiliary subunit161
    Teh2CG15004VDRC KK 104951VG Na+ auxiliary subunit161
    Teh4CG15003VDRC GD 11621VG Na+ auxiliary subunit131
    Teh4CG15003VDRC KK 102161VG Na+ auxiliary subunit161
    trpCG7875DRSC 31649Light-activated Ca++ channel101
    trpCG7875VDRC GD 1366Light-activated Ca++ channel141
    • This table includes the list of UAS-RNAi transgenic lines that, when driven exclusively in LNvs, did not produced statistically significant alterations in free running period and/or percentage of rhythmicity compared with pdf,dicer/+ control genotype (after Student's t test analysis). N indicates number of independent experiments performed; n indicates number of individuals tested. The appearance of a gene in this table suggests that it may not be involved in the circadian function of LNvs. However, most of these RNAi constructs have not been individually tested for their actual performance on ion channel knock-down. Moreover, it should be noticed that for some genes, such as Shal and Ca-α1T, one RNAi construct was able to affect behavior, while others were not. Further investigations are necessary to determine the roles of these channels in LNvs function. Besides the efficiency of the particular RNAi transgenic line, another phenomenon that should be taken into account is that, in some cases, a homeostatic compensation of ion channel downregulation might have taken place. For instance, it is surprising that targeting the gene coding for the only classical voltage-gated sodium channel paralytic (para) in LNvs has not resulted in a behavioral phenotype. Most likely, this genetic manipulation has produced compensation, as it has been reported to happen for such an important and therefore highly regulated ion conductance (Lin and Baines, 2015). Interestingly, downregulation of para accessory subunit tipE does affect circadian behavior (see Table 2), indicating that less compensatory mechanisms may be in place to counterbalance such genetic manipulation, and that affecting para in this indirect way is probably having a detrimental effect on LNvs ability to fire action potentials. For all these reasons, this table only provides the information that the specific RNAi transgenic lines shown, in the particular conditions we have used, are not able to affect circadian behavior when driven in LNvs. Further analysis is necessary to make stronger statements in all cases. V: voltage, G: gated, DRSC: Drosophila RNAi Screening Center, VDRC: Vienna Drosophila Resource Center.

    • View popup
    Table 5.

    Sleep parameters after genetic manipulation ofIh

    GenotypeTotal sleep (min)Daytime sleep (min)Nighttime sleep (min)Bout duration (min)Sleep bout numberLatency lights on (min)Latency lights off (min)Activity indexnNTemperature (°C)
    Ihf033551026.6 ± 17.8a430.0 ± 14.3a599.9 ± 8.4a17.6 ± 0.6b58.5 ± 1.8a25.0 ± 5.8b15.3 ± 1.9b4.24 ± 0.18a56325
    Ihf03355/+956.9 ± 21.6a,b394.6 ± 11.8a560.5 ± 15.0a,b29.0 ± 1.6a36.4 ± 1.7b71.5 ± 6.3a27.1 ± 3.7a2.18 ± 0.08b69
    w1118922.2 ± 20.8b380.5 ± 12.6a533.4 ± 17.4b28.4 ± 1.7a35.3 ± 1.6b78.7 ± 7.3a27.6 ± 3.0a2.02 ± 0.05b66
    c929-Gal4;tub-Gal80TS>UAS-IhRNAi921.7 ± 31.6a464.1 ± 16.1a457.7 ± 21.6a17.0 ± 0.9a57.5 ± 1.9a18.1 ± 3.1a15.9 ± 2.7b2.16 ± 0.07b58230
    c929-Gal4;tub-Gal80TS/+773.0 ± 50.7b432.6 ± 25.5a340.4 ± 30.3b15.7 ± 0.9a49.4 ± 1.8b51.0 ± 12.0a45.7 ± 8.1a1.88 ± 0.05c31
    UAS-IhRNAi/+793.5 ± 38.1b424.8 ± 21.5a368.7 ± 21.1b16.0 ± 0.8a50.6 ± 1.4b25.5 ± 7.5a17.4 ± 2.9b2.52 ± 0.09a61
    R6-Gal4;tub-Gal80TS>UAS-IhRNAi1264.9 ± 14.2a636.7 ± 7.6a630.7 ± 21.6a37.1 ± 2.5a41.7 ± 2.0c2.2 ± 0.7c16.8 ± 3.7b2.63 ± 0.08a85330
    R6-Gal4;tub-Gal80TS/+1195.6 ± 19.6b605.9 ± 10.8b589.6 ± 30.3b31.2 ± 3.1b47.3 ± 1.9b5.4 ± 1.1b24.7 ± 6.2b2.16 ± 0.06b87
    UAS-IhRNAi/+1015.7 ± 23.7c515.0 ± 12.8c504.6 ± 21.1c20.5 ± 0.8c52.5 ± 1.2a13.6 ± 2.8a18.2 ± 2.4a2.21 ± 0.08b89
    pdf-Gal4, UAS-dicer2;tub-Gal80TS> UAS-IhRNAi955.9 ± 27.8a603.5 ± 12.3ab357.7 ± 20.5a25.8 ± 1.1b39.2 ± 1.6a17.2 ± 3.3b19.4 ± 4.6b1.82 ± 0.03a61230
    pdf-Gal4, UAS-dicer2;tub-Gal80TS/+847.9 ± 15.7b632.4 ± 7.4a215.5 ± 12.5c30.1 ± 1.0a30.0 ± 1.8b22.5 ± 1.7a36.5 ± 5.6a1.64 ± 0.03b63
    UAS-IhRNAi/+848.7 ± 20.0b573.1 ± 12.9b274.9 ± 15.6b22.4 ± 1.1c41.9 ± 1.7a14.8 ± 1.9b24.5 ± 3.8a1.81 ± 0.03a61
    c929-Gal4>UAS-IhRNAi980.5 ± 29.9a496.1 ± 15.0a484.1 ± 17.2a18.2 ± 1.3a60.3 ± 2.1a8.6 ± 2.4c21.7 ± 2.6b1.98 ± 0.04a72325
    c929-Gal4/+793.1 ± 26.8b394.4 ± 13.5c401.4 ± 17.1b15.5 ± 0.9a52.7 ± 1.5b56.5 ± 7.7a32.3 ± 3.0a1.89 ± 0.03a,b71
    UAS-IhRNAi/+919.0 ± 29.5a444.5 ± 15.9b474.9 ± 17.3a16.9 ± 1.1a58.7 ± 1.6a19.9 ± 4.0b26.5 ± 5.1b1.80 ± 0.03b70
    R6-Gal4>UAS-IhRNAi1111.7 ± 27.7a545.9 ± 15.7a551.2 ± 14.9a27.2 ± 0.6a53.3 ± 2.9a6.8 ± 2.6b30.9 ± 7.2a2.21 ± 0.09a65325
    R6-Gal4/+854.5 ± 35.9b409.7 ± 18.0b440.9 ± 20.8b15.6 ± 1.2b58.2 ± 2.3a19.0 ± 3.0a26.6 ± 4.4a2.06 ± 0.03a71
    UAS-IhRNAi/+826.9 ± 28.1b400.6 ± 16.4b423.6 ± 15.5b14.1 ± 2.9b59.9 ± 1.4a32.9 ± 5.4a24.2 ± 2.5a1.81 ± 0.03b70
    pdf-Gal4, UAS-dicer2>UAS-IhRNAi715.9 ± 37.8b330.6 ± 20.7b385.3 ± 21.6b14.3 ± 0.9b52.2 ± 1.9a27.5 ± 6.2b36.5 ± 6.2a1.75 ± 0.04b64225
    pdf-Gal4, UAS-dicer2/+714.0 ± 29.3b320.8 ± 15.3b393.3 ± 18.3b14.0 ± 0.7b52.4 ± 1.6a70.0 ± 7.1a42.4 ± 6.3a1.73 ± 0.03b56
    UAS-IhRNAi/+937.5 ± 28.1a414.3 ± 18.4a525.5 ± 15.2a18.7 ± 0.9a52.6 ± 1.7a39.0 ± 6.5b21.3 ± 4.6b1.89 ± 0.03a64
    • The following sleep parameters on the different genetic manipulations presented in the first column are shown: total sleep, daytime sleep, nighttime sleep, sleep bout duration, bout amount, latency to lights on, latency to lights off, and activity index (defined as the average activity counts in the active minutes). The last column shows the temperature at which each experiment was performed. Average ± SEM (Standard Error of the Mean) of N experiments using a final n number of individuals are displayed. Different letters indicate significant differences (p < 0.05) after non parametric Kruskal–Wallis statistical analysis with multiple comparisons (p adjustment method = BH). Sleep parameters where the experimental genotype showed statistically significant differences compared with genetic controls are displayed in bold.

Back to top

In this issue

The Journal of Neuroscience: 41 (4)
Journal of Neuroscience
Vol. 41, Issue 4
27 Jan 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
High-Frequency Neuronal Bursting is Essential for Circadian and Sleep Behaviors in Drosophila
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
High-Frequency Neuronal Bursting is Essential for Circadian and Sleep Behaviors in Drosophila
Florencia Fernandez-Chiappe, Lia Frenkel, Carina Celeste Colque, Ana Ricciuti, Bryan Hahm, Karina Cerredo, Nara Inés Muraro, María Fernanda Ceriani
Journal of Neuroscience 27 January 2021, 41 (4) 689-710; DOI: 10.1523/JNEUROSCI.2322-20.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
High-Frequency Neuronal Bursting is Essential for Circadian and Sleep Behaviors in Drosophila
Florencia Fernandez-Chiappe, Lia Frenkel, Carina Celeste Colque, Ana Ricciuti, Bryan Hahm, Karina Cerredo, Nara Inés Muraro, María Fernanda Ceriani
Journal of Neuroscience 27 January 2021, 41 (4) 689-710; DOI: 10.1523/JNEUROSCI.2322-20.2020
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • bursting neuron
  • Drosophila melanogaster
  • HCN
  • Ih
  • ion channel
  • pigment dispersing factor

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • The Functional Anatomy of Nociception: Effective Connectivity in Chronic Pain and Placebo Response
  • Complex Impact of Stimulus Envelope on Motor Synchronization to Sound
  • The Molecular Substrates of Second-Order Conditioned Fear in the Basolateral Amygdala Complex
Show more Research Articles

Systems/Circuits

  • Hippocampal Sharp-Wave Ripples Decrease during Physical Actions Including Consummatory Behavior in Immobile Rodents
  • Developmental Olfactory Dysfunction and Abnormal Odor Memory in Immune-Challenged Disc1+/− Mice
  • Functional Roles of Gastrin-Releasing Peptide-Producing Neurons in the Suprachiasmatic Nucleus: Insights into Photic Entrainment and Circadian Regulation
Show more Systems/Circuits
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.